Pharmaceutical News and Articles

Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Pretreated Extensive-Stage Small Cell Lung Cancer

BASKING RIDGE, NJ AND RAHWAY, NJ, August 18, 2025 Ifinatamab deruxtecan (I-DXd) has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Dru

Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Redmond, WA and Princeton, NJ August 18, 2025 SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb today announced tha

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

Soligenix, Inc. (Nasdaq SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rar

Blood Pressure Measurement Methods Have Clinically Important Variance

Differences across blood pressure (BP) measurement methods show clinically important variance in readings, according to a review published online Aug. 19 in the

FDA Approves KETARx (ketamine) for Surgical Pain Management

Hundreds May Have Been Exposed to Rabies in Wyoming Park Cabins

MONDAY, Aug. 18, 2025 Hundreds of people may have been exposed to rabies after staying in cabins infested with bats at Wyoming s Grand Teton National Park. As m

FDA Approves Ketamine Product, KETARx, for Surgical Pain Management

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management. Ketamine is the only psychedelic or psyche

Historically Redlined Neighborhoods Face Lack of Rapid Access to EMS

Living in historically redlined areas is associated with a lack of rapid access to emergency medical services (EMS), according to a study published online Aug.

Parents' Occupational Exposure Tied to Offspring's Autism Severity

Several classes of parental occupational exposures are associated with autism spectrum disorder (ASD) severity and several behavioral subscales, according to a

Nike Co-Founder And Wife Donate $2B to Cancer Research at OHSU, Largest U.S. University Gift

MONDAY, Aug. 18, 2025 Nike co-founder Phil Knight and his wife, Penny, will donate 2 billion to Oregon Health Science University (OHSU) to expand cancer researc